ATF4 and cancer: SLC7A11 transcript levels were also decreased with both ATF4 knockdown and rapamycin in the PTEN-deficient cancer cell lines LNCaP and PC3, although SLC7A11 expression was relatively more resistant to rapamycin in PC3 cells (Figure 6—figure supplement 1D, E).